Enovis (NYSE:ENOV) vs. Health Catalyst (NASDAQ:HCAT) Financial Comparison

Enovis (NYSE:ENOV) and Health Catalyst (NASDAQ:HCAT) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, analyst recommendations, risk, institutional ownership, earnings and valuation.

Institutional and Insider Ownership

98.5% of Enovis shares are held by institutional investors. Comparatively, 85.0% of Health Catalyst shares are held by institutional investors. 2.7% of Enovis shares are held by insiders. Comparatively, 2.6% of Health Catalyst shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Risk & Volatility

Enovis has a beta of 1.7, meaning that its stock price is 70% more volatile than the S&P 500. Comparatively, Health Catalyst has a beta of 1.46, meaning that its stock price is 46% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Enovis and Health Catalyst, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Enovis	0	0	6	0	3.00
Health Catalyst	0	7	5	0	2.42

Enovis presently has a consensus target price of $51.00, indicating a potential upside of 64.62%. Health Catalyst has a consensus target price of $6.1818, indicating a potential upside of 85.08%. Given Health Catalyst’s higher probable upside, analysts plainly believe Health Catalyst is more favorable than Enovis.

Profitability

This table compares Enovis and Health Catalyst’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Enovis	-37.80%	6.78%	3.73%
Health Catalyst	-31.67%	-7.21%	-3.28%

Valuation and Earnings

This table compares Enovis and Health Catalyst”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Enovis	$2.11 billion	0.84	-$825.49 million	($14.25)	-2.17
Health Catalyst	$316.09 million	0.74	-$69.50 million	($1.51)	-2.21

Health Catalyst has lower revenue, but higher earnings than Enovis. Health Catalyst is trading at a lower price-to-earnings ratio than Enovis, indicating that it is currently the more affordable of the two stocks.

Summary

Enovis beats Health Catalyst on 10 of the 14 factors compared between the two stocks.

About Enovis

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

About Health Catalyst

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.